跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DICLOFENAC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DICLOFENAC
Authorized
STANDARD
DICLOFENAC
pharma stulln inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
41d2fb346d3a0cc9
Company
pharma stulln inc.
Type
Standard
Approval Details
Approval Id
41d2fb346d3a0cc9
Drug Approval Canada Name
DICLOFENAC
Product Name
DICLOFENAC
Status
Marketed
Status Date
2019-03-29
Original Market Date
2019-03-29
Din
02475065
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:02.00
Atc Original
S01BC03 DICLOFENAC
Atc Name
s 01 bc 03
Aig Number
0114417004
Company Name
pharma stulln inc.
Company Address
6500 Trans Canada Highway, Suite 400, Pointe-Claire, Quebec, Canada, H9R 0A5
Active Ingredients
DICLOFENAC SODIUM
0.1 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
41d2fb346d3a0cc9
Type
Standard
Back to Health Canada Approvals